CClinicalTrials.gg
Sign In
CompletedNCT05459012TAPAGEUpdated Nov 21, 2023

Patient Education in Pregnant Women With Asthma

An observational study in Asthma, sponsored by CHU de Reims. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-11-21.

Sponsored by CHU de Reims · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
5
Ages
18 Years and older
Sex
All
01

Study summary

Pregnancy may impact treatment adherence in women with asthma. This is a major risk factor for asthma exacerbation, which may have an important impact for both women and the babies. This study aims to evaluate the impact of a targeted patient education action tailored for pregnant women with asthma.

02

Conditions studied

  • Asthma

Browse trials for

03

In context

Asthma

3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.

This study's enrollment of 5 is below the median of 150 across 970 observational studies indexed under Asthma.

Browse Asthma studies →

Lead sponsor

CHU de Reims is the lead sponsor of 267 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

women with asthma

Inclusion criteria

  • Adult pregnant women with asthma

Exclusion criteria

Exclusion Criteria:

  • women not able to speak and/or read French language
  • women protected by the law
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
5 participants (actual)
Patient registry
No

Groups and cohorts

  • pregnant women with asthma

    Other: follow-up

Interventions

  • Otherfollow-up

    Questionnaire of Quality of life

06

What researchers measure

Primary outcomes

  1. Change from Asthma quality of life between two periods : before intervention and 3 month after the intervention

    The physician gives Asthma quality of life questionnaire (AQLQ) before intervention and 3 month after the intervention

    Time frame: before and 3 month after the intervention

07

Study locations

1 site
  • Chu Reims
    Reims, 51092, France
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05459012
Lead sponsor
CHU de Reims
Responsible party
Sponsor
First posted
Jul 14, 2022
Start date
Sep 19, 2022
Primary completion
Jun 27, 2023
Completion
Oct 31, 2023
Last update
Nov 21, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Asthma→

Other studies from this sponsor

CHU de Reims

Start the discussion